Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Global Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Forecast 2024-2030" report has been added to ResearchAndMarkets.com's offering.
The Biopharmaceuticals Manufacturing Consumables Testing Market size was estimated at USD 558.75 million in 2023, USD 621.39 million in 2024, and is expected to grow at a CAGR of 11.71% to reach USD 1,213.54 million by 2030. 
Market Segmentation & Coverage
This research report categorizes the Biopharmaceuticals Manufacturing Consumables Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product Type
- Consumables
- Instruments
- Services
- Type
- Compendial Testing
- Custom Testing
- Laboratory Testing
- Chemical Analysis Testing
- Enzyme Testing
- Stability Testing
- Sterility Testing
- Application
- Biopharmaceuticals Production
- Quality Control & Assurance
- Research & Development
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 189 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $621.39 Million |
| Forecasted Market Value (USD) by 2030 | $1213.54 Million |
| Compound Annual Growth Rate | 11.7% |
| Regions Covered | Global |
Companies Mentioned
- Agilent Technologies, Inc.
- Alcami Corporation
- Almac Group Limited
- ALS Limited
- ASTM International
- Avance Biosciences, Inc.
- Becton, Dickinson and Company
- BioConvergence LLC
- BioLife Solutions Inc.
- bioMerieux SA
- Boston Analytical, Inc.
- Bureau Veritas SA
- Catalent, Inc
- Charles River Laboratories International, Inc.
- Curia Global, Inc.
- DEKRA SE
- EM Topco Limited
- Eurofins Scientific SE
- Intertek Group PLC
- Laboratory Corporation of America
- LGM Pharma, LLC
- Life Technologies (India) Pvt Ltd.
- Merck KGaA
- MISTRAS Group, Inc.
- Neopharm Labs Inc.
- Ortho-Clinical Diagnostics, Inc.
- Pace Analytical Services, LLC
- Pacific BioLabs, Inc.
- ProtaGene, GmbH.
- Sartorius AG
- SGS SA
- Sotera Health Company
- STERIS PLC
- Tentamus Group GmbH
- Thermo Fisher Scientific Inc.
- TUV SUD ELAB GmbH
- WuXi AppTec, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/7sebg7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
